Appeals Court Revives Antitrust Case Against McDonald’s
In a recent development, the 7th U.S. Circuit Court of Appeals in Chicago has reinstated allegations that McDonald’s Corp violated federal antitrust law by imposing
Home
Page 444
Bankman-Fried Appeals Bail in FTX Exchange Collapse Case
Sam Bankman-Fried, the once high-flying 31-year-old entrepreneur and former billionaire, has lodged an appeal against a recent court ruling that led to his incarceration pending
BYD Defies Odds, Tops China’s Automotive Market
BYD Co Ltd, a prominent player in the new energy vehicle sector, has demonstrated its resilience by retaining its position as China’s top-selling automotive brand
Positive Start to Week as Inflation and Jobs Data Awaited
The stock market commenced the trading week on a positive note, with indices displaying significant gains in early morning trading. Investor sentiment was influenced by
Wall Street Swings Amid Powell’s Speech, Closes Up
After a tumultuous start to the trading day, Wall Street managed to claw its way into positive territory on Friday, largely attributed to the Fed
Jeff Bezos’s Arrived Homes Thrive Amidst Surging Housing Prices
In a striking display of prescience, Amazon.com Inc. Founder Jeff Bezos’s investment in the Seattle-based startup Arrived Homes has gained remarkable traction, even as housing
Instacart Sets Stage for IPO Listing Following Filing
After much anticipation, Instacart, the renowned grocery delivery app, has unveiled its IPO filing, detailing its plans for a stock market flotation on New York’s
Detroit Automakers Face Strike Threat as UAW Issues Ultimatum
The United Auto Workers (UAW) union sent a resounding message to the Detroit Three automakers on Friday, intensifying tensions by setting a deadline for their
Market Finds Balance After Powell’s Jackson Hole Speech
In a day of tumultuous trading, stock markets regained their composure on Friday afternoon following Fed Chair Jerome Powell’s speech at the annual Jackson Hole
AstraZeneca Contests Drug Pricing Laws in Legal Battle
AstraZeneca (AZN) has emerged as the sixth pharmaceutical company and the foremost international entity to enter the legal fray against Xavier Becerra, the US Health
